Phase I Trial of Smallpox Vaccine

NCT00046397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

195

Enrollment

NIH

Sponsor class

Conditions

Healthy

Interventions

DRUG: Modified Vaccinia Virus Ankara TBC-M

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)